ReviewFrontiers in oncology2022

Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer.

Maria Gemelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.